Abstract
In recent years, health geographers have focused on studies related to COVID-19, proposing frameworks for understanding the Brazilian territory and synthesizing its spatial diffusion pattern. In this process, there is a need for a deeper intra-urban analysis of the impact of COVID-19 on the health of populations in small-to medium-sized cities in non-metropolitan areas. Thus, we aimed to articulate the theory of Social Determinants of Health (SDH) and geoprocessing methodologies to analyze the health situation in the municipality of Presidente Prudente (SP). For this purpose, we used Inverse Distance Weighted (IDW) and Geographically Weighted Regression (GWR) as methodological tools. IDW performs a weighted interpolation among neighbors, generating heat surfaces, whereas GWR executes a spatial regression, presenting correlations between variables. For the analyzed period (March 2020 to July 2021), we found medium-strong correlations between cases and the non-white population, per capita income, and elderly population (R² = 0.46, 0.39, and 0.49, respectively). For deaths, only the elderly population was relevant (R² = 0.34) and the correlation between cases and deaths was satisfactory (R² = 0.65 and 0.51). The results highlight areas of concern, demonstrating that geoprocessing is an important tool for health surveillance, identifying areas and population characteristics that require greater attention, and geography as an important science that helps to understand the impacts of COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Research Ethics Committee of the Faculty of Science and Technology (FCT) of Universidade Estadual Paulista (UNESP) on December 18, 2023 (protocol number 6,589,379). Subsequently, an addition was carried out and approved on April 15, 2024 (protocol number 6,765,975).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos